Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1675
| Despition | TOR1A Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1674 | Human KCNIP3 Protein (AC1674) | 5 µg | inquiry |
| ACPP-1697 | Mouse Midkine Protein (AC1697) | 5 µg | inquiry |
| ACPP-1668 | Human BDNF Protein, His (AC1668) | 5 µg | inquiry |
| ACPP-1195 | CaMKII gamma Blocking Peptide (AC1195) | 250 µg | inquiry |
| ACPP-1563 | Human STX4 Protein (AC1563) | 5 µg | inquiry |
| ACPP-1499 | Mouse RAPSN Protein (AC1499) | 5 µg | inquiry |
| ACPP-1084 | Recombinant Human Autotaxin Protein (Functional) (AC1084) | 10 µg | inquiry |
| ACPP-1346 | GFAP Blocking Peptide (AC1346) | 250 µg | inquiry |
| ACPP-1837 | Rat SCGN Protein (AC1837) | 2 µg | inquiry |
| ACPP-1099 | Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.